Skip to content

Advertisement

  • Correction
  • Open Access

Correction to: Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation

  • 1Email author,
  • 2,
  • 2,
  • 2,
  • 2,
  • 2,
  • 3 and
  • 4
Trials201920:322

https://doi.org/10.1186/s13063-019-3463-8

  • Received: 24 May 2019
  • Accepted: 24 May 2019
  • Published:

The original article was published in Trials 2019 20:182

Correction to: Trials

https://doi.org/10.1186/s13063-019-3272-0

After publication of the original article [1], the authors have notified us of an error in language used in the text:
  • The first sentence of the 6th paragraph under the Methods sections should read “Training was completed for each individual patient.”

  • The first sentence of the 3rd paragraph under Training of patients and site staff should read: “The site staff underwent face-to-face training and hands-on experience with the devices at investigator meetings or online training modules and took 2 hours to complete on average.”

The phrase “took 2 hours to complete on average” was moved from the first sentence to the second one.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Divisions of Rheumatology and Allergy and Clinical Immunology, Johns, Hopkins University, 5200 Eastern Avenue, MFL Center Tower Room 404, Baltimore, MD 21224, USA
(2)
Eli Lilly and Company, Indianapolis, USA
(3)
Eli Lilly Services India Private Limited, Bangalore, India
(4)
Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Windmill Road Headington, Oxford, UK

Reference

  1. Bingham CO, et al. Use of daily electronic patient-reported outcome (PRO) diaries in randomized controlled trials for rheumatoid arthritis: rationale and implementation. Trials. 2019;20:182. https://doi.org/10.1186/s13063-019-3272-0.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2019

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement